My take on the Phase 1 safety study is that they may have had more dropouts than were anticipated, so the study may have been extended. If I remember the study correctly, all had to be in the study for 60 days. If one or more person had to be added, the study won't be concluded until 60 days after that person was added.
I would hope that we learn more at the quarterly, which should be scheduled shortly, and perhaps by then the trial may have concluded.
Gary
(0)
(0)
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links